SoVote

Decentralized Democracy

House Hansard - 317

44th Parl. 1st Sess.
May 24, 2024 10:00AM
Context: House Hansard - 317 - May/24/24
Mr. Scott Reid (Lanark—Frontenac—Kingston, CPC)
  • May/24/24 12:04:23 p.m.
  • Watch
Mr. Speaker, pulmonary arterial hypertension, also known as PAH, is a disease that blocks arteries in the lungs, causing high blood pressure in the lungs and damaging heart tissue. Patients diagnosed with PAH have, on average, three years to live. In the United States, a drug called sotatercept was recently approved by the FDA. This drug increases quality of life and lifespan for PAH patients and even, in some cases, reverses the damage caused by the disease. When will this life-saving drug be approved for use in Canada?
89 words
  • Hear!
  • Rabble!
  • star_border